NIKE, Inc. (NKE) Stock Analysis
Is NKE a good investment?
NIKE, Inc. (NKE) has a Plutrex AI rating of 20.0/100 as of November 08, 2026, indicating a Strong Sell consensus. The stock is halal-compliant per AAOIFI standards. Key strength: Cash of $8.37B and FCF of $2.105B annually provide genuine balance sheet floor, support dividend (~4% yield) and buybacks without liquidity crisis — prevents terminal distress scenario. Main concern: 5-year EPS CAGR of -5.1% versus industry +6.05% (1,115bps gap) with P/E of 18.5x (7.4% premium to peers): PEG is undefined/negative — NKE is simultaneously the slowest-growing and most expensive stock on a growth-adjusted basis in its peer group; FY2027 guidance confirms structural not cyclical deterioration.
Investment Summary
NKE at $38.59 remains a Strong Sell. The stock has drifted another +3.5% higher since our last report ($37.30 → $38.59), moving further above the analyst consensus target of $36.34, which now implies -5.8% downside. Nothing material has changed: revenue growth is -4.3% (industry peers growing +1.16%), 5-year EPS CAGR is -5.1% (industry +6.05%), P/E is 18.5x on a business expected to shrink earnings for half a decade. The PEG ratio is undefined/negative — the single most damning valuation signal possible. Operating margin of 7.92% trails the industry average of 11.11% by 319bps; gross margin of 43.3% is 952bps below the peer average of 47.95%. News sentiment scored 20/100 with 5 of 10 articles negative. Headlines like 'Nike stock down 38% in 2026' and 'NIKE's Fiscal 2027 Outlook Puts Pace Savings Against Revenue Risk' confirm the structural deterioration thesis. The stock has overshot even sell-side optimism. FCF of $2.1B and $8.37B cash provide a floor, but at 18.5x earnings with no growth, the stock is 20-35% overvalued on a pure fundamental basis. Fair value remains in the $24-$32 range.
Key Strengths
- Cash of $8.37B and FCF of $2.105B annually provide genuine balance sheet floor, support dividend (~4% yield) and buybacks without liquidity crisis — prevents terminal distress scenario
- Near-term EPS growth of 17.77% next year modestly exceeds industry average of 16.46%, suggesting restructuring savings provide a temporary earnings rebound that may attract momentum traders in the near term
- Global brand equity across 150+ countries represents a qualitative moat preventing terminal collapse — the brand has survived prior cycles and maintains pricing power evidenced by 43.3% gross margin
Key Concerns
- 5-year EPS CAGR of -5.1% versus industry +6.05% (1,115bps gap) with P/E of 18.5x (7.4% premium to peers): PEG is undefined/negative — NKE is simultaneously the slowest-growing and most expensive stock on a growth-adjusted basis in its peer group; FY2027 guidance confirms structural not cyclical deterioration
- Analyst consensus target of $36.34 is BELOW current price of $38.59 (-5.8% implied downside); news sentiment 20/100 with 5 negative articles; revenue contracting -4.3% while industry grows; stock now +3.5% above even our prior sell trigger, adding further distance from intrinsic value range of $24-$32
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
NKE's fundamentals have not improved in any material dimension since the prior report. Gross margin of 43.3% is respectable in isolation but 952bps below the industry average of 47.95%, indicating competitors retain more value per dollar of sales. Operating margin of 7.92% is 319bps below the industry average of 11.11%, meaning roughly 35 percentage points of gross margin is consumed by SG&A/overhead — a severe operational inefficiency. Net margin of 6.74% trails the industry average of 8.78% by 204bps. ROE of 21.56% appears healthy but is 269bps below the peer average of 24.25% and is partially leverage-inflated (D/E of 0.56). Revenue growth is -4.3% versus industry +1.16% (a 541bps gap). Earnings growth is -2.1% versus industry +6.88% (a 889bps gap). The 5-year EPS CAGR of -5.1% versus industry +6.05% represents an 1,115bps structural divergence — the most critical long-term metric. P/E of 18.5x carries a 7.4% premium to the industry average of 17.23x, despite inferior profitability and growth on every dimension. The near-term 17.77% EPS growth estimate (modestly above industry 16.46%) is the only positive metric, but analysts themselves believe this bounce is not sustained — the 5-year trajectory resumes decline. FCF of $2.1B and $8.37B cash prevent a liquidity crisis but do not resolve the valuation or growth problem. Intrinsic value based on FCF at 10% discount rate with 0% terminal growth: ~$27/share; applying 12-14x P/E (appropriate for secular earnings decline) to current EPS suggests $24-$32 fair value range. The stock at $38.59 carries 20-35% downside risk.
News Sentiment
Nike is struggling to find its footing as 2026 shapes up to be one of the worst years in the company's recent history. The sneaker giant's stock has plunged 38% this year, a stunning fall for a brand that once seemed untouchable, and investors are wondering if the bottom is finally in — or if more pain lies ahead. Headlines asking 'What Would Warren Buffett Do With Nike Stock Down 38% in 2026?' reflect the existential uncertainty gripping Wall Street about one of America's most iconic companies. There were brief moments of optimism: Nike gained 13.9% in a single month as fresh product launches sparked hope of a turnaround, but the rally quickly raised more questions than answers — specifically, whether this bounce was sustainable or just a head-fake. The article 'Is the Turnaround Rally Sustainable?' captured the market's skepticism perfectly. The harder truth is buried in Nike's fiscal 2027 outlook, where analysts note the company is pitting cost-saving programs against real revenue risk — meaning even if Nike cuts expenses, top-line deterioration could wipe out those gains. Meanwhile, with the stock still trading at a premium valuation despite weak growth, 'Is NIKE Stock Worth Buying as Valuation Stays High Amid Weak Growth?' summarizes the dilemma facing buyers today. For everyday investors: Nike makes great shoes, but right now the business is shrinking, the stock is expensive relative to what you're getting, and Wall Street's own price targets say the stock should be lower than it trades today.
Risk Assessment
PRIMARY RISK (BEARISH): Further price appreciation driven by short-covering or momentum ignores fundamentals — the stock has already risen 38% in context of a broader rally despite the business declining. At $38.59 with analyst targets at $36.34, risk-reward is structurally negative. SECONDARY RISK (BEARISH): FY2027 guidance of continued revenue decline could force sell-side target cuts below $36.34, adding another leg down. TERTIARY RISK (BULLISH — tail risk): A genuine China recovery, a competitor misstep, or activist involvement could trigger a sharp re-rating; this is not in base case. MITIGATION: Do not initiate new longs at current price. Existing holders should exit on any strength. Set a watchlist alert for entry zone $24.00-$28.50 and require one of three catalysts before re-entry: (a) China revenue stabilization quarter-over-quarter, (b) positive revenue growth for one quarter, or (c) 5-year EPS CAGR revised into positive territory by consensus.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is NKE a halal stock?
Yes, NIKE, Inc. (NKE) is halal-compliant per AAOIFI standards as of the latest quarterly review.
What is Plutrex's AI rating for NKE?
NIKE, Inc. (NKE) has a Plutrex AI rating of 20.0/100 with a Strong Sell consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is NKE a good investment?
According to Plutrex AI, NKE has a Strong Sell rating (20.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in NKE?
US stocks like NKE can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. ElBarake provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in NKE?
Plutrex AI identifies the main risks for NKE by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.